Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle gyrokinesis shows promise for easing fatigue in young cancer survivors

NCT ID NCT07137091

Symptom relief Sponsor: MTI University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a gentle exercise program called Gyrokinesis could help reduce cancer-related fatigue in children and teens who had been treated for a brain tumor. 80 participants who had finished active treatment at least a year earlier took part. The study measured fatigue using a questionnaire and physical endurance with a six-minute walk test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Oct 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed and treated for a brain tumor during childhood or adolescence (0-≤18 years). * Treated for a PBT during the previous 10 years, starting from date of diagnosis. * Aged ≥6 years 0 months at the start of the trial. * Off therapy/active treatment for pediatric brain tumor (PBT) for 12 months at the start of the trial. * No known signs of clinical or radiological tumor progression at last follow-up. * Danish is the sole or primary language (enabling provision of validated assessment tools). * Patient and family have provided consent for inclusion in the trial. Exclusion Criteria: * History of recent poorly controlled seizures. * Motor tics or Tourette syndrome (including family history of tic disorder). * Known diagnosis of Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder. * Known diagnosis of Full Scale Intelligence Quotient (FSIQ) of \<50. * Pregnancy. Participants known to be pregnant or breastfeeding at screening/registration will not enrolled

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fatigue are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm Fatigue

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fatigue

Contacts and locations

Locations

  • faculty of physical therapy ,Cairo University

    Cairo, 3753450, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.